Cargando…

Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Despite the promising results not all patients with advanced non-small cell lung cancer benefit from immunotherapy. Immunotherapy may cause severe adverse events, and therefore, it is important to improve the selection of patients for this treatment. The current biomarker, PD-L1, is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mouritzen, Mette T., Ladekarl, Morten, Hager, Henrik, Mattesen, Trine B., Lippert, Julie B., Frank, Malene S., Nøhr, Anne K., Egendal, Ida B., Carus, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526901/ https://www.ncbi.nlm.nih.gov/pubmed/37760450 http://dx.doi.org/10.3390/cancers15184480

Ejemplares similares

Tumour-associated CD66b(+) neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
por: Carus, A, et al.
Publicado: (2013)

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
por: Mouritzen, Mette T., et al.
Publicado: (2021)

A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)
por: Rasmussen, Louise Skau, et al.
Publicado: (2023)

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Dyhl-Polk, Anne, et al.
Publicado: (2021)

MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples
por: Mattesen, Trine B., et al.
Publicado: (2021)

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
por: Drobni, Zsofia D., et al.
Publicado: (2020)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Durable targeting of B-lymphocytes in living mice
por: Cascalho, M., et al.
Publicado: (2018)

Tumor Ulceration, Reduced Infiltration of CD8-Lymphocytes, High Neutrophil-to-CD8-Lymphocyte Ratio and Absence of MC Virus are Negative Prognostic Markers for Patients with Merkel Cell Carcinoma
por: Naseri, Simon, et al.
Publicado: (2020)

Psychosocial factors and T lymphocyte counts in Brazilian peacekeepers
por: Monteiro da Silva, Angela M, et al.
Publicado: (2015)

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors
por: Young, Richard Benjamin, et al.
Publicado: (2022)

Perceived stress in adolescence and labour market participation in young adulthood - a prospective cohort study
por: Winding, Trine Nøhr, et al.
Publicado: (2023)

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia
por: Carus, Andreas, et al.
Publicado: (2013)

Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis
por: Gambichler, T, et al.
Publicado: (2010)

Absolute lymphocyte and neutrophil counts in neonatal ischemic brain injury
por: Povroznik, Jessica M, et al.
Publicado: (2018)

Durable clinical benefit of letrozole in leptomeningeal metastasis of breast cancer
por: Takanashi, Toshihiro, et al.
Publicado: (2019)

Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity
por: Kabak, M., et al.
Publicado: (2021)

Diphtheria Antibodies and T lymphocyte Counts in Patients Infected With HIV-1
por: Speranza, Francisco A. B., et al.
Publicado: (2012)

Tumor LAG‐3 and NY‐ESO‐1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Jung, Eun Hee, et al.
Publicado: (2021)

The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia
por: de Jager, Cornelis P. C., et al.
Publicado: (2012)

Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
por: Diehl, Adam, et al.
Publicado: (2017)

Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer
por: Lee, Ye Jin, et al.
Publicado: (2022)

Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura
por: Boothe, James T., et al.
Publicado: (2017)

Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer
por: Amini, Arya, et al.
Publicado: (2015)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
por: Wang, Xiangxue, et al.
Publicado: (2022)

Evaluating the association between socioeconomic position and cardiometabolic risk markers in young adulthood by different life course models
por: Kempel, Mia Klinkvort, et al.
Publicado: (2022)

Let us think about lymphocyte counts!
por: Hamerschlak, Nelson
Publicado: (2012)

Danish Pancreatic Cancer Database
por: Fristrup, Claus, et al.
Publicado: (2016)

Early Postpartum Stress, Anxiety, Depression, and Resilience Development among Danish First-Time Mothers before and during First-Wave COVID-19 Pandemic
por: Ladekarl, Monica, et al.
Publicado: (2021)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
por: Erhabor, Osaro, et al.
Publicado: (2009)

Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study
por: Karanth, Suman S., et al.
Publicado: (2014)

Predictions of CD4 lymphocytes’ count in HIV patients from complete blood count
por: Rodríguez, Javier O, et al.
Publicado: (2013)

Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2018)

Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease
por: McDermott, Mary M., et al.
Publicado: (2018)

Live long and prosper: durable benefits of early-life care in banded mongooses
por: Vitikainen, Emma I. K., et al.
Publicado: (2019)

Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy
por: Ilyinskii, Petr O., et al.
Publicado: (2018)

Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study
por: Bjørn, Anne-Mette B, et al.
Publicado: (2013)

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_el1uea924sn98dp9j4u3qk8ucg